Showing 3 results for Heart Failure
Babak Bharvand, Mehrdad Namdari, Yaghob Sherkhani, Afshin Nazari,
Volume 7, Issue 1 (1-2006)
Abstract
Background: Heart failure is one of the common cardiovascular diseases and
digoxin has the positive effect on it. But unfortunately in spite of its positive effect on
heart failure therapeutic and toxic level of it in patients is different and close to each
other. The aim of this research was determination of digoxin serum level in failur
heart patients.
Materials and methods: In this cross-sectional study 31 patients with heart failure
and consumption digoxin refer to clinic were assessment. Some important factors
including age, clearance creatinie, ejection fraction, urea, potassium, calsium and
digoxin level were measured.
Findings: The statistical analysis of data showed that there was a correlation
(r=0.57, p<0.01) between age and digoxin level. Digoxin level correlated positively
with serum urea (r=0.046, p<0.01) creatinine(r=0.049, p<0.01), and potassium(r=0.47,
p<0.01).
Conclusions: It was concluded that continues monitoring of digital level with due
attention to creatinine clearance and measurement of digoxin level for prevent of
digoxin toxicity was necessary was necessary to prevent digoxin toxicity.
Samad Nazarpoor, Roshanak Akbari, Arash Amin, Zahra Rahimi, Amin Adinevand, Samad Darabian,
Volume 23, Issue 0 (11-2021)
Abstract
Background: High pulmonary hypertension is a progressive and life threatening disease that affects the pulmonary arteries and the right side of the human heart. The aim of this study was to evaluate the relative frequency of pulmonary hypertension in patients referred to the echocardiography unit of Shahid Rahimi Hospital in Khorramabad city 2020.
materials and methods:In this descriptive-analytical study, 600 echocardiographs performed in the echocardiography unit of Shahid Rahimi Hospital in Khorramabad were studied and information such as demographic and clinical features were extracted; Data were collected using SPSS 22 software and statistically analyzed.
Results: Out of 600 patients who underwent echocardiography, 87 (14.5%) had pulmonary hypertension. Out of 87 patients with pulmonary hypertension, 71% (62 patients) were over 55 years old. Also, 51% (45 people) were women. About 56% (49 patients) had heart failure with decreased output fraction and valvular diseases. Among the demographic variables, a significant relationship was observed between age and pulmonary hypertension.
Conclusion: Due to the fact that this disease is more common in people with heart failure and older people, so diagnostic and therapeutic measures should be more sensitive than these people.
Arash Amin, Morteza Amraei, Nasrollah Moradifar,
Volume 23, Issue 0 (11-2021)
Abstract
Background: It is not long before the outbreak of coronavirus disease (COVID-19) and its transformation into a pandemic. Over the course of late December 2019, studies have shown that cardiovascular comorbidities are more common in patients with COVID-19 and that these patients are at higher risk for complications and mortality; however, it is not yet clear whether underlying cardiovascular diseases pose a separate risk or whether they are associated with other factors, such as age and sex. The purpose of this study is to review the underlying cardiovascular diseases during the COVID-19. For this purpose, the main review articles using keywords such as “COVID-19”, ‘Coronavirus”, “SARS-CoV-2”, “Cardiovascular diseases”, “Myocarditis”, “Acute coronary syndromes”, “Heart failure”, and “Ischemic heart disease: were collected from PubMed, Scopus, Google Scholar, Web of Science and other reputable databases. The results showed that myocardial injury was present in more than 25% of critical cases and appeared in two patterns: acute myocardial injury and dysfunction during the presentation and myocardial injury caused by exacerbation of the disease. Continuation of angiotensin converting enzyme inhibitors and angiotensin receptor inhibitors is recommended based on the evidence at this time. A number of promising therapies are under consideration, but none have been clinically proven to be effective to date. The present study indicates that during the corona pandemic, more attention should be paid to people with cardiovascular disease and effective treatments should be used for them based on new studies.
